HomeAI · summaries
Storia in 7 fonti
Replimune rebounds to win FDA approval of melanoma drug
The accelerated clearance follows two earlier rejections and the support of an advisory panel that disputed the arguments of FDA scientists.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
Replimune rebounds to win FDA approval of melanoma drug
The accelerated clearance follows two earlier rejections and the support of an advisory panel that disputed the arguments of FDA scientists.
- ·
medpagetoday.com
FDA Finally OKs Twice-Rejected Melanoma Drug
Approved in combination with nivolumab for patients who progress on prior anti-PD-1 therapy
